Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Hoth Therapeutics Inc (HOTH)

Hoth Therapeutics Inc (HOTH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 37,576
  • Shares Outstanding, K 13,420
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,700 K
  • 60-Month Beta 0.96
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 5.89

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/20
See More
  • Average Estimate -0.14
  • Number of Estimates 1
  • High Estimate -0.14
  • Low Estimate -0.14
  • Prior Year -0.13
  • Growth Rate Est. (year over year) -7.69%

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.75 +1.82%
on 05/27/20
4.96 -43.55%
on 05/19/20
-0.71 (-20.23%)
since 05/05/20
3-Month
2.60 +7.90%
on 03/19/20
7.00 -60.00%
on 03/23/20
-1.10 (-28.21%)
since 03/05/20
52-Week
2.60 +7.90%
on 03/19/20
9.07 -69.13%
on 06/11/19
-4.18 (-59.89%)
since 06/05/19

Most Recent Stories

More News
Developing a COVID-19 Vaccine Quickly Proving to be a Daunting Task But Progress Still Expected

, /PRNewswire/ -- Rapid development of a vaccine to prevent the global health crisis is a global imperative, and defining the stakes and potential hurdles is critical because regulatory and medical decisions...

HOTH : 2.80 (unch)
GILD : 76.75 (-1.02%)
INO : 11.93 (+0.42%)
SRNE : 4.12 (+6.74%)
VXRT : 2.42 (-7.63%)
Hoth Therapeutics Provides Shareholder Update on Therapeutics Pipeline

, /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today provided an update on its pipeline of therapeutics including six compounds in various stages of clinical...

HOTH : 2.80 (unch)
The Benchmark Company Announces Closing of Public Offering of $5.0 Million for Hoth Therapeutics, Inc.

The Benchmark Company announced the closing on March 27th of an Underwritten Public Offering for Hoth Therapeutics, Inc. (NASDAQ: HOTH) of 1,818,182 shares of common stock at a public offering price of...

HOTH : 2.80 (unch)
Hoth Therapeutics Announces Closing of Public Offering of Common Stock

, /PRNewswire/ -- Hoth Therapeutics, Inc. ("Hoth" or the "Company") (NASDAQ: HOTH), a biopharmaceutical company, announced today the closing of its previously announced underwritten public offering...

HOTH : 2.80 (unch)
Hoth Therapeutics Announces the Appointment of Michael Peters, Ph.D. to Scientific Advisory Board

, /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced that , Ph.D., has joined the company's Scientific Advisory Board. Dr. Peters is the inventor of...

HOTH : 2.80 (unch)
Hoth Announces Pricing of Public Offering of Shares of Common Stock

, /PRNewswire/ -- Hoth Therapeutics, Inc. ("Hoth" or the "Company") (NASDAQ: HOTH), a biopharmaceutical company, today announced the pricing of an underwritten public offering of 1,818,182 shares of...

HOTH : 2.80 (unch)
Hoth Announces Proposed Public Offering of Common Stock

, /PRNewswire/ -- Hoth Therapeutics, Inc. ("Hoth" or the "Company") (NASDAQ: HOTH), a biopharmaceutical company, today announced that it intends to offer shares of its common stock in an underwritten...

HOTH : 2.80 (unch)
Hoth Therapeutics Licenses Novel Peptide COVID-19 Therapeutic

, /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced licensing technology and intellectual property exclusively from ("VCU") for a novel peptide therapeutic...

HOTH : 2.80 (unch)
Voltron Therapeutics Publishes Letter to Shareholders

, /PRNewswire/ -- Voltron Therapeutics, Inc. announces today a letter to the shareholders.

HOTH : 2.80 (unch)
Hoth Therapeutics Procures Full Licensing Rights for BioLexa Platform, Atopic Dermatitis Treatment

, /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced today that the company has obtained exclusive worldwide licensing rights to the BioLexa Platform,...

HOTH : 2.80 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Trade HOTH with:

Business Summary

Hoth Therapeutics Inc. is a development stage biopharmaceutical company. It focused on therapeutics for patients suffering from indications such as atopic dermatitis, also known as eczema. The company's BioLexa(TM) Platform is a proprietary, patented drug compound platform. Hoth Therapeutics Inc. is...

See More

Key Turning Points

2nd Resistance Point 2.89
1st Resistance Point 2.84
Last Price 2.80
1st Support Level 2.76
2nd Support Level 2.73

See More

52-Week High 9.07
Fibonacci 61.8% 6.60
Fibonacci 50% 5.83
Fibonacci 38.2% 5.07
Last Price 2.80
52-Week Low 2.60

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar